scispace - formally typeset
Open AccessJournal ArticleDOI

Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture

Ruth Chia, +166 more
- 15 Feb 2021 - 
- Vol. 53, Iss: 3, pp 294-303
TLDR
This article performed whole-genome sequencing in large cohorts of Lewy body dementia (LBD) cases and neurologically healthy controls to study the genetic architecture of this understudied form of dementia, and to generate a resource for the scientific community.
Abstract
The genetic basis of Lewy body dementia (LBD) is not well understood. Here, we performed whole-genome sequencing in large cohorts of LBD cases and neurologically healthy controls to study the genetic architecture of this understudied form of dementia, and to generate a resource for the scientific community. Genome-wide association analysis identified five independent risk loci, whereas genome-wide gene-aggregation tests implicated mutations in the gene GBA. Genetic risk scores demonstrate that LBD shares risk profiles and pathways with Alzheimer's disease and Parkinson's disease, providing a deeper molecular understanding of the complex genetic architecture of this age-related neurodegenerative condition.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Parkinson disease-associated cognitive impairment.

TL;DR: Parkinson disease (PD) is the second most common neurodegenerative disorder, affecting >1% of the population ≥65 years of age and with a prevalence set to double by 2030 as mentioned in this paper.
Journal ArticleDOI

Current Therapies in Clinical Trials of Parkinson's Disease: A 2021 Update.

TL;DR: Parkinson's disease (PD) is a progressive neurodegenerative disorder that currently has no cure, but treatments are available to improve PD symptoms and maintain quality of life.
Journal ArticleDOI

Lysosomal dysfunction in neurodegeneration: emerging concepts and methods

TL;DR: In this paper , the authors discuss technological advances that have propelled deeper understanding of the lysosome in neurodegeneration, from elucidating the functions of LBS-related disease risk variants at the level of the organelle, cell, and tissue, to the development of disease-specific biological models that recapitulate disease manifestations.
Journal ArticleDOI

Shared mechanisms across the major psychiatric and neurodegenerative diseases

TL;DR: In this article , the authors integrate the GWAS results with human brain transcriptomes and proteomes to identify cis-and trans- transcripts and proteins that are consistent with a pleiotropic or causal role in each disease, referred to as causal proteins.
Journal ArticleDOI

Hallmarks of neurodegenerative diseases

TL;DR: In this article , the authors present evidence for the following eight hallmarks of neurodegenerative diseases: pathological protein aggregation, synaptic and neuronal network dysfunction, aberrant proteostasis, cytoskeletal abnormalities, altered energy homeostasis and DNA and RNA defects.
References
More filters
BookDOI

Modern Applied Statistics with S

TL;DR: A guide to using S environments to perform statistical analyses providing both an introduction to the use of S and a course in modern statistical methods.
Journal ArticleDOI

ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data

TL;DR: The ANNOVAR tool to annotate single nucleotide variants and insertions/deletions, such as examining their functional consequence on genes, inferring cytogenetic bands, reporting functional importance scores, finding variants in conserved regions, or identifying variants reported in the 1000 Genomes Project and dbSNP is developed.
Journal ArticleDOI

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

TL;DR: The APOE-epsilon 4 allele is associated with the common late onset familial and sporadic forms of Alzheimer9s disease (AD) in 42 families with late onset AD.
Journal ArticleDOI

Second-generation PLINK: rising to the challenge of larger and richer datasets

TL;DR: The second-generation versions of PLINK will offer dramatic improvements in performance and compatibility, and for the first time, users without access to high-end computing resources can perform several essential analyses of the feature-rich and very large genetic datasets coming into use.
Related Papers (5)

Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium

Ian G. McKeith, +45 more
- 27 Dec 2005 - 

Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium

Ian G. McKeith, +95 more
- 04 Jul 2017 -